People

I graduated with a medical degree and master’s degree in clinical medicine from Tianjin Medical University, China, was awarded PhD in Molecular Microbiology from National University of Singapore with research experience in infectious diseases, immunology, molecular biology and mouse models . My research focuses on SARS-CoV-2 detection and rapid TB diagnostic development.

I graduated with PhD in Biomedical Sciences from University of Nottingham, Malaysia. I have experience working in the field of vaccinology, immunology, molecular biology and microbiology research. My PhD focused on developing Toxoplasma gondii vaccine using murine models for preclinical testing. I work on investigating the immunological responses and potential therapies against tuberculosis.

I obtained my PhD in Molecular Epidemiology from Universiti Malaysia Sarawak, Malaysia. My PhD focused on developing PCR assay in differentiating the two subpopulations of the simian malaria Plasmodium knowlesi and determining its clinical manifestations in humans. I am currently interested in host pathogen interactions in tuberculosis patients with type 2 diabetes mellitus.

I graduated with MSc in Medical and Health Sciences with a specialization in Molecular Parasitology from the International Medical University, Malaysia. My previous research focused on viral metagenomics, COVID-19 therapeutics, and the use of PET/CT in studying SARS-CoV-2 infection and its sequelae. Currently, my research interest lies in diabetes mellitus and tuberculosis, with the aims of reducing immunopathology and improving treatment outcomes.

I graduated from University of Science Malaysia with an honours degree in Applied Science (Biotechnology). I am experienced in mammalian cell cultures, molecular biology as well as animal handling and management. My interest is in TB animal models. Currently, I am working on dysregulated angiogenesis in poorly-controlled DM drives immunopathology in pulmonary TB.

I studied Molecular Biology and Biotechnology in the University of Hong Kong (HKU) and graduated with a Bachelor's degree of Science. I am currently pursuing a PhD degree in the National University of Singapore (NUS). My current research interests lie in the platelet-neutrophil interactions and immunopathology in Tuberculosis. Through such research, I wish to reveal the mechanism of TB inflammation in search for strategies to attenuate TB-mediated tissue damage and autoimmunity, and thereby improve the outcome of TB treatment.

I graduated from the University of Medicine 2 in Yangon, Myanmar. In 2014, I moved to Singapore to work with the menopause research team at the Department of Obstetrics & Gynaecology, where I played a key role in driving the "Integrated Women's Health Program," an ongoing longitudinal cohort that aims to address the healthcare needs of mid-life Singaporean women. Over a period of 6 years, I have developed research protocols, formulated study questionnaires, and made significant contributions to the design and management of clinical trials in the department.

My previous work focused on the epidemiology of midlife women's health and population-level interventions, particularly for osteoporosis, hip fracture, and menopause. In recognition of my contributions in the field, I have received the Top Scoring Abstract Award from RCOG World Congress in 2018 and the Best Young Investigator Oral Presentation Prize at the Asia Pacific Menopause Federation Conference in 2017. I also have a number of publications in high-impact journals, including the International Journal of Epidemiology, JAMA Network Open, and Maturitas.

Currently, I am pursuing a PhD at the NUS School of Medicine. Recently, I have become interested in the epidemiology and outcomes of respiratory infections and now focused on exploring the potential of this field, particularly in Tuberculosis and Influenza.

I graduated from the University of Cambridge and am currently working as a geriatrician at the National University Hospital. I am studying part-time for my Masters in Clinical Investigation, which is funded by the competitive NMRC Research Training Fellowship. I am also a clinical tutor at NUS. My research interest is in immunosenescence. I believe infections are an important contributor to morbidity and mortality in older adults. My current project is looking at the mechanisms underlying the differing immune responses to the COVID-19 vaccination in younger and older adults. Through this research, I aim to discover ways to extend the healthy years our older adults are able to enjoy. I also participate actively in clinical research, looking into major geriatric syndromes of frailty, sarcopenia and cognitive impairment.

Nicholas is an Infectious Diseases Associate Consultant with NUH, having completed his specialist training in 2024. He is currently pursuing a Masters of Clinical Investigation with NUS. He has a keen interest in infections in immunocompromised hosts. His research interests are varied, and has over 80 peer-reviewed publications indexed on Scopus. He has been involved in studies on COVID-19, Staphylococcus aureus and is embarking on a Phase II multi-centre randomised trial on central nervous system tuberculosis.

I am a medical student at NUS Yong Loo Lin School of Medicine. I have had prior training and experience as a medical technologist through my studies in the Diploma of Biomedical Science (Singapore Polytechnic). My current research interests lie in infectious diseases, particularly host-pathogen interactions in patients with concurrent Tuberculosis and Type 2 Diabetes Mellitus.

I graduated with a medical degree from University College London and I am currently pursuing a PhD at the National University of Singapore. My research explores the interplay between chronic inflammation and tuberculosis infection, with a broader interest in immune aging and host-pathogen interactions. I have prior research experience in microbial pathogenesis and antimicrobial resistance. I have worked in clinical medicine in the UK, Australia, and New Zealand, and I bring both medical and scientific perspectives to infection-related immunology.